Clin Mol Hepatol.
2024 Oct;30(4):728-734. 10.3350/cmh.2024.0469.
Engineering HBV-specific T cells for the treatment of HBV-related HCC and HBV infection: Past, Present, and Future. Editorial on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting”
- Affiliations
-
- 1Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore
- KMID: 2560082
- DOI: http://doi.org/10.3350/cmh.2024.0469
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting
- Occult Hepatitis B Virus Infection and Hepatocellular Carcinoma
- Detection of Hepatitis B Virus DNA by Polymerase Chain Reaction in Patients with Hepatocellular Carcinoma
- The Role of Hepatitis B Virus Infection in the Development of Hepatitis C Virus-related Hepatocellular Carcinoma
- Identification of integrated hepatitis B virus DNA sequences in human hepatocellular carcinomas in Korea
